Other-Guidance: De Novo Classification Process (Evaluation of Au
New
ICR Details
Reginfo record details
0910-0844
201707-0910-009
Historical Active
HHS/FDA
CDRH
De Novo Classification Process (Evaluation of Automatic Class III Designation)
New collection (Request for a new OMB Control Number)
No
Regular
Approved without change
09/18/2017
08/03/2017
table that charts list comparision
Inventory as of this Action
Requested
Previously Approved
09/30/2020
36 Months From Approved
57
0
0
7,330
0
0
0
0
0
The ICR describes the information collection involved with the De Novo classification process for medical devices. FDA uses the information in the De Novo request to evaluate whether the medical device may be reclassified from Class III to Class I or II, and if applicable, to determine the general and/or special controls necessary to sufficiently regulate the medical device. Respondents to the information collection are medical device manufacturers.
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.